hotspot -WSS

hotspot

author：leisure time 2025-09-28 01:38:23 - browse：471

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Illumina names Agilent executive as new CEO

WSS

Amazon on where the company's health care bets are headed next

The 10 drugs up first for Medicare price negotiation

What drug price negotiations mean for Medicare Part D

A look at other Americans who have crossed into North Korea over the years

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

What we know about the American soldier detained in North Korea

leisure time

hotspot

knowledge

How to save PrEP access — and even expand it

AstraZeneca chief proposes a novel edit to the drug pricing bill

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'Make People Better': The CRISPR babies story you probably don't know

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

New air purifier tech could be key to improving indoor air quality

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Cancer drug shortages should be causing more outrage

How to fix cancer clinical trials' diversity problem

knowledge

The (many) problems with a new study criticizing cancer screening

'Make People Better': The CRISPR babies story you probably don't know

How to fix cancer clinical trials' diversity problem

The (many) problems with a new study criticizing cancer screening

'Make People Better': The CRISPR babies story you probably don't know

Illumina names Agilent executive as new CEO

hotspot

focus

knowledge

knowledge